Where does Io Therapeutics, Inc rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Io Therapeutics, Inc ranks #4,889 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Io Therapeutics, Inc hold?

Io Therapeutics, Inc holds 71 US utility patents granted between 2016 and 2025, spanning 10 technology areas.

What is Io Therapeutics, Inc's Innovation Score?

Io Therapeutics, Inc has an Innovation Score of 40.6 out of 100 (top 35% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Io Therapeutics, Inc's patent grant rate increasing or decreasing?

Io Therapeutics, Inc's recent grant velocity is +145% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Io Therapeutics, Inc's patents?

Io Therapeutics, Inc's patents average 19.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Io Therapeutics, Inc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Io Therapeutics, Inc

Q: What technology areas does Io Therapeutics, Inc focus on?

Io Therapeutics, Inc's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 69 patents. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 71 granted patents across 10 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Io ranks #4,889 of 49,997 tracked US assignees by granted-patent volume, with 71 patents across 10 technology areas.

#4,889
of 49,997 US assignees by volume: Top 35%
by Innovation Score (40.6/100): 19.0
avg claims per patent: +145%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R4889 · US Corporation #4,889 · 71 grants

GRANTS-SMALL · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 71 grants
TOP-DECILE #4,889/49,997
PHOTO-FINISH Hyperfine Research
CPC-FOCUS A61K · 10 areas
INNOV-PAR 40.6/100
CLAIMS-RICH 19.0 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +145% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hyperfine Research, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Actelion Pharmaceuti… · near

41
Io Therapeutics · this assignee

41
K4connect · near

41
Kyowa Kirin · near

41
Mbda Deutschland · near

41
3D Lighting… · lowest

7

What this shows Io's Innovation Score is 40.6/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Io's grants concentrate

Io Therapeutics, Inc is a focused PatentsView assignee: 10 CPC subclasses with 97.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (16 grants) versus a trough of 2 in 2016. By volume, Io sits between Hyperfine Research, Inc. and LS Cable & System Ltd..

Io's three-year grant acceleration

From 2019–2021 to 2022–2024, Io Therapeutics, Inc moved from 39 to 19 grants (0.49x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Hyperfine Research

71
Innoplexus

71
International Rec…

71
Inventus Holdings

71
Kikkoman

71
Klein Tools

71
L&L Candle

71
LS Cable & System

71
Io Therapeutics ◀

71

What this shows Io holds 71 patents at rank #4,889, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Io

By rank, the assignees closest to #4,889 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Io's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Io, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (41 here).

Actelion Pharmaceuticals Ltd. 41 Kyowa Kirin Co., Ltd. 41 Mbda Deutschland GmbH 41 K4connect Inc. 41

Similar claim depth

Nearest assignees by average claims per patent (19.0 here).

University OF Hawaii 19.0 avg Syniverse Technologies, LLC 19.0 avg University Of Delaware 19.0 avg Heraeus Medical GmbH 19.0 avg

Io's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 35% higher than 65% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Io Therapeutics, Inc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	2.8%
2017	2	2.8%
2018	7	9.9%
2019	9	12.7%
2020	16	22.5%
2021	14	19.7%
2022	3	4.2%
2023	11	15.5%
2024	5	7.0%
2025partial year	2	2.8%

Which technologies does Io Therapeutics, Inc patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 69

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 66

Y02A - Technologies FOR Adaptation TO Climate Change 28

C07K - Peptides 17

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 14

C07C - Acyclic OR Carbocyclic Compounds 7

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 7

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 5

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 2

C07D - Heterocyclic Compounds 2

Top 10 of 10 technology areas

Where it ranks

Overall rank by patents

#4,889

of 49,997 tracked assignees

Innovation Score

40.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Io Therapeutics, Inc's patent record in context - here's where to go next.

Io Therapeutics, Inc's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 97.2% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #4,889 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Io Therapeutics, Inc against Hyperfine Research, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.